Td Asset Management Inc Alx Oncology Holdings Inc Transaction History

Td Asset Management Inc

  • $107 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024
SELL
$10.95 - $16.79 $234,329 - $359,306
-21,400 Reduced 30.4%
49,000 $546,000
Q4 2023

Feb 12, 2024
BUY
$4.81 - $15.38 $338,624 - $1.08 Million
70,400 New
70,400 $1.05 Million
Q4 2020

Feb 16, 2021
SELL
$34.11 - $112.26 $460,109 - $1.51 Million
-13,489 Closed
0 $0
Q3 2020

Nov 10, 2020
BUY
$29.36 - $47.1 $396,037 - $635,331
13,489 New
13,489 $509,000

Others Institutions Holding ALXO

# of Institutions
101
Shares Held
39.7M
Call Options Held
134K
Put Options Held
17.4K
View Full List

About ALX ONCOLOGY HOLDINGS INC

ALXO Quotes by TradingView
  • Ticker ALXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,747,100
  • Market Cap $66M
  • Description
  • ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...
More about ALXO
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email